Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
Mutz, I; Urban, C; Gadner, H; Jürgenssen, OA; Zoubek, A.
Results of neuroblastoma treatment in Austria (1979-1984)
Padiatr Padol. 1986; 21(3): 269-274.
PubMed
- Co-Autor*innen der Med Uni Graz
- Urban Ernst-Christian
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Abstract:
- During the period from 1979 until 1984 55 children were registered: 4 in Evan-stage I, 13 in stage II, 16 in stage III, 18 in stage IV and 4 in stage IV-S. 39 of these 55 patients have been followed for a minimum of two years. The current two year survival rate is 10/10 in stages I and II, 6/13 in stage III, 3/14 in stage IV and 2/2 in stage IV-S. These results demonstrate but a slight improvement in patients with stage II since the last Austrian statistic 1974. Despite modern chemotherapy the chance for survival of children with stage III or IV neuroblastoma is poor and better treatment modalities should be searched for.
- Find related publications in this database (using NLM MeSH Indexing)
- Antineoplastic Combined Chemotherapy Protocols - therapeutic use
- Austria - therapeutic use
- Child - therapeutic use
- Combined Modality Therapy - therapeutic use
- Follow-Up Studies - therapeutic use
- Humans - therapeutic use
- Neoplasm Staging - therapeutic use
- Neuroblastoma - drug therapy